Keith Goldan

Keith Goldan

Director of Finance/CFO at NUPATHE INC

Net worth: 3 M $ as of 31/05/2026

54 year
Health Technology
Consumer Services
Commercial Services

Profile

Mr. Keith A. Goldan is an Independent Director at Abeona Therapeutics, Inc., a Chief Financial Officer at Syndax Pharmaceuticals, Inc., a Chief Financial Officer & Senior Vice President at NuPathe, Inc. and a Chief Financial Officer & Vice President at Biosyn, Inc. He is on the Board of Directors at Abeona Therapeutics, Inc. Mr. Goldan was previously employed as a Chief Financial Officer by OptiNose, Inc., a CFO, Treasurer & Senior Vice President by Fibrocell Science, Inc., a Chief Financial Officer & Director by PuriCore Plc, a Chief Financial Officer by PuriCore International Ltd., and an Associate Director by Century Capital Associates.
He received his undergraduate degree from Robert H.
Smith School of Business and an MBA from The Wharton School of the University of Pennsylvania.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
01/06/2026 139,252 ( 0.16% ) 3 M $ 31/05/2026
15/04/2026 32,751 ( 0.06% ) 189 301 $ 31/05/2026

Keith Goldan active positions

CompaniesPositionStart
NUPATHE INC Director of Finance/CFO 04/05/2009
SYNDAX PHARMACEUTICALS, INC. Director of Finance/CFO 13/06/2022
ABEONA THERAPEUTICS INC. Director/Board Member 01/04/2026
Director of Finance/CFO -

Former positions of Keith Goldan

CompaniesPositionEnd
OPTINOSE, INC. Director of Finance/CFO 10/06/2022
FIBROCELL SCIENCE, INC. Director of Finance/CFO 01/01/2017
Director of Finance/CFO 31/10/2008
REALM THERAPEUTICS PLC Director of Finance/CFO 13/10/2008
Founder -
See the detail of Keith Goldan's experience

Training of Keith Goldan

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

49

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Retail Trade

Consumer Services

Consumer Services

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!